Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Obsidian Therapeutics Inc.
Market Cap
$14.44M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.24M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.17
3Y Avg
-1.46
5Y Avg
-1.36
Market Cap
$14.04M
Earnings Per Share (EPS)
-2.11
TTM Avg
-3.38
3Y Avg
-4.90
5Y Avg
-6.31
Market Cap
$15.03M
Earnings Per Share (EPS)
-13.07
TTM Avg
-13.67
3Y Avg
-19.10
5Y Avg
-23.67
Market Cap
$15.04M
Earnings Per Share (EPS)
-2.46
TTM Avg
-7.80
3Y Avg
-9.74
5Y Avg
-7.20
Market Cap
$13.78M
Earnings Per Share (EPS)
-11.33
TTM Avg
-17.89
3Y Avg
-30.77
5Y Avg
-41.73
Market Cap
$13.71M
Earnings Per Share (EPS)
-1.87
TTM Avg
-10.75
3Y Avg
-23.11
5Y Avg
-21.98
Market Cap
$13.34M
Earnings Per Share (EPS)
-29.90
TTM Avg
-175.25
3Y Avg
-40254.86
5Y Avg
-180507.78
Market Cap
$15.58M
Earnings Per Share (EPS)
-0.77
TTM Avg
-1.25
3Y Avg
-1.82
5Y Avg
-1.86
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Obsidian Therapeutics Inc. (OBX) | $14.44M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.24M | N/A | -1.17 | -1.46 | -1.36 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.04M | -2.11 | -3.38 | -4.90 | -6.31 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.03M | -13.07 | -13.67 | -19.10 | -23.67 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.04M | -2.46 | -7.80 | -9.74 | -7.20 |
| Passage Bio, Inc. (PASG)vs › | $13.78M | -11.33 | -17.89 | -30.77 | -41.73 |
| IN8bio, Inc. (INAB)vs › | $13.71M | -1.87 | -10.75 | -23.11 | -21.98 |
| Vyome Holdings, Inc. (HIND)vs › | $13.34M | -29.90 | -175.25 | -40254.86 | -180507.78 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.58M | -0.77 | -1.25 | -1.82 | -1.86 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.83M | -0.78 | -8.29 | -9461.74 | -302593.36 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
